echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical Research Articles > Researchers reduced the severity of sleep apnea by at least 30%

    Researchers reduced the severity of sleep apnea by at least 30%

    • Last Update: 2021-08-09
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    A new study published in The Journal of Physiology shows that researchers have successfully reused two existing drugs to reduce the severity of sleep apnea by at least 30%


    In the UK, approximately 1.


    Those who are not treated for sleep apnea are more likely to suffer from cardiovascular disease, dementia, and depression, and are two to four times more likely to have a crash


    Despite nearly 30 years of research, there is no approved drug therapy to treat this disease


    Flinders University (Flinders University) Adelaide Institute for Sleep Health (Adelaide Institute for Sleep Health) Professor and Director, Nervous System Research Institute (NeuRA) Chief Research Scientist Professor Danny Eckert (Danny Eckert) passed Reusing the two existing drugs and testing their efficacy on patients with sleep apnea has brought scientists one step closer to success


    Previous studies have shown that reboxetine and butyl bromide can help people without sleep apnea to keep their muscles active during sleep and help them breathe


    By changing the use of the drug, the researchers used a large number of recording instruments to measure whether reboxetine and butyl bromide can successfully target the main cause of sleep apnea


    This includes balancing the electrical activity of the muscles around the airways, preventing people from collapsing their throats while sleeping, and improving the regulation of carbon dioxide and breathing during sleep


    The results of the study showed that these drugs did increase muscle activity around the participants’ airways and reduced the severity of sleep apnea in participants by a third


    Almost all the people in our study have improved sleep apnea


    These new discoveries enable researchers to further refine these types of drugs, making them more beneficial than currently discovered


    Professor Eckert commented on the study:

    He said: "We are very excited, because the current treatment of sleep apnea is limited, which may be a painful process for many people


    He continued: "Similarly, we will test whether these treatments can be combined with other existing drugs and see if we can further improve their efficacy


    So far, the main method of treating sleep apnea is to wear a mask to sleep, or continuous positive airway pressure therapy (CPAP), which benefits millions of people


    In addition, the effectiveness of second-line therapies, such as mouthguards installed by dentists, can be unpredictable and expensive


    ###


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.